Trial Profile
A real world, multicentre study to investigate the effect of Daclatasvir and Asunaprevir treatment in patients with Heaptitis C virus genotype 1b infection with severe liver fibrosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Apr 2019
Price :
$35
*
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 03 Apr 2017 New trial record
- 04 Mar 2017 Results published in the Journal of Gastroenterology and Hepatology